These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 7899350)
21. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Graham DY; Opekun A; Lew GM; Klein PD; Walsh JH Gastroenterology; 1991 Jun; 100(6):1571-5. PubMed ID: 2019363 [TBL] [Abstract][Full Text] [Related]
23. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096 [TBL] [Abstract][Full Text] [Related]
24. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer. García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331 [TBL] [Abstract][Full Text] [Related]
25. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602 [TBL] [Abstract][Full Text] [Related]
26. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test. Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008 [TBL] [Abstract][Full Text] [Related]
27. [Helicobacter pylori infection and basal levels of serum gastrins in patients with duodenal ulcer and subjects with normal endoscopy]. Gisbert JP; Boixeda D; Vila T; Cantón R; Alvarez Baleriola I; Defarges V; Martín de Argila C Med Clin (Barc); 1996 Mar; 106(9):325-8. PubMed ID: 8667697 [TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360 [TBL] [Abstract][Full Text] [Related]
29. [Detection of Helicobacter pylori and antimicrobial resistance in gastric biopsy specimens]. Cağdaş U; Otağ F; Tezcan S; Sezgin O; Aslan G; Emekdaş G Mikrobiyol Bul; 2012 Jul; 46(3):398-409. PubMed ID: 22951652 [TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy. Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671 [TBL] [Abstract][Full Text] [Related]
32. Enhanced somatostatin secretion into the gastric juice with recovery of basal acid output after Helicobacter pylori eradication in gastric ulcers. Hayakawa T; Kaneko H; Konagaya T; Shinozaki K; Kasahara A; Funaki Y; Mori S; Yokoi T; Hirooka Y; Kusugami K; Kakumu S J Gastroenterol Hepatol; 2003 May; 18(5):505-11. PubMed ID: 12702041 [TBL] [Abstract][Full Text] [Related]
33. [One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. Gisbert JP; Mur M; Boixeda D; Ceña G; Martín de Argila C; Alvarez Baleriola I; Abraira V; García Plaza A Med Clin (Barc); 1997 Apr; 108(14):524-9. PubMed ID: 9190436 [TBL] [Abstract][Full Text] [Related]
35. Antral gastrin cell hyperfunction and Helicobacter pylori infection. Annibale B; Rindi G; D'Ambra G; Marignani M; Solcia E; Bordi C; Delle Fave G Aliment Pharmacol Ther; 1996 Aug; 10(4):607-15. PubMed ID: 8853766 [TBL] [Abstract][Full Text] [Related]
36. [Decrease of basal levels of gastrin following H. pylori eradication]. Gisbert JP; Boixeda D; Vila T; de Rafael L; Alvarez Baleriola I; Moreira V; Martín de Argila C; Arocena C; García Plaza A Rev Esp Enferm Dig; 1995 Feb; 87(2):99-107. PubMed ID: 7748715 [TBL] [Abstract][Full Text] [Related]
37. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519 [TBL] [Abstract][Full Text] [Related]
38. Host mechanisms: are they the key to the various clinical outcomes of Helicobacter pylori infection? Calam J Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):375-82. PubMed ID: 9476195 [TBL] [Abstract][Full Text] [Related]
40. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up]. Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]